A company that works on so-called liquid biopsies, tests that search for cancer in blood or urine, says its preliminary trials indicate the test is successful at catching early-stage lung cancer. Reuters reports:
OncoCyte said it believes the data provides a level of accuracy well above what is necessary for a commercially successful test.
“If the assay continues to perform at these levels, it could create a significant improvement in the standard of care in lung nodule management,” Dr. Anil Vachani, the study’s lead investigator, said in a statement.
Vachani, from the University of Pennsylvania, will present details of the latest findings at a medical meeting in late May, the company said.
Get the whole story at www.reuters.com
